Tag: Cancer

Scientists at the University of Wisconsin School of Medicine and Public Health are breaking new ground to make cancer cells more susceptible to attack by the body’s own immune system. Working in mice, a team led by Jamey Weichert, professor of radiology, and Zachary Morris, professor of human oncology, is combining two different techniques in

For people who‘ve undergone treatments for cancer, hair loss is a common but nevertheless stressful side effect. And, contrary to popular belief, the hard part isn’t over when your hair starts to return. Here, survivor Tali Aronoff opens up about how losing her hair changed her perspective — and why she ultimately never grew it

Researchers from the University of Missouri School of Medicine have discovered a treatment combination that significantly reduces tumor growth and extends the life span of mice with liver cancer. This discovery provides a potentially new therapeutic approach to treating one of the leading causes of cancer-related death worldwide. A cancer translational research team consisting of

Patients with locally advanced cervical cancer benefit significantly from an innovative radiotherapy technique co-developed by MedUni Vienna under the direction of Richard Pötter and Christian Kirisits. The technique provides better tumor control and produces fewer side-effects. This is substantiated by the results of the prospective, international, multi-center study, EMBRACE I, conducted under the direction of

We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights. Sir Simon Stevens, chief executive, said 165,000 patients will take part in the scheme earmarked to start next summer. Research on people with signs of the disease suggests the Galleri blood test

Many cancer researchers can claim to have devised “smart bombs.” What has been missing is the stealth bomber—a delivery system that can slip through the body’s radar defenses. Oncolytic viruses, or viruses that preferentially kill cancer cells, have been discussed and tested for decades. An oncolytic virus against melanoma was approved by the FDA in

Sometimes, too much of a good thing can turn out to be bad. This is certainly the case for the excessive cell growth found in cancer. But when cancers try to grow too fast, this excessive speed can cause a type of cellular aging that actually results in arrested growth. Scientists at Duke-NUS Medical School

WEDNESDAY, Nov. 18, 2020 — Vitamin D supplementation is associated with a reduction in the incidence of advanced cancer, with the strongest reduction seen among those with normal weight, according to a study published online Nov. 18 in JAMA Network Open. Paulette D. Chandler, M.D., M.P.H., from Harvard Medical School in Boston, and colleagues conducted

(HealthDay)—Even as the coronavirus pandemic has postponed the delivery of many kinds of health care, a new study suggests that delaying cancer treatment by even a month can raise your risk of dying by 6% to 13%, and that risk keeps rising the longer treatment is delayed. The increased risk of death for seven types

Most people born in the UK today can expect to live until they’re about 80. Having been diagnosed with incurable breast cancer some 18 months ago, aged just 55, I’ll be lucky to make it to my 60s. How do I deal with that knowledge? I find ways, otherwise I would go mad worrying about

We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights. Consuming chilli peppers may provide a bulwark against the two biggest killers – cardiovascular disease and cancer, according to new research. Previous studies have enumerated the benefits of consuming capsaicin – the

Menarini Silicon Biosystems has announced the publication of a research study providing support for the reliability of using circulating tumor cell (CTC) count to guide frontline therapy choice for patients with estrogen receptor-positive (ER+), HER2-negative (HER2) metastatic breast cancer. Published in the November issue of JAMA Oncology, this is the first study to support clinical

Regenstrief Institute and Indiana University School of Medicine research scientists have developed and tested one of the first U.S.-based models to predict personal risk for advanced precancerous polyps and colon cancer in average risk individuals. Colorectal cancer is the third most common cancer and second most lethal cancer in the U.S. Especially during the COVID-19

Cancers sometimes escape our immune defenses because of the over-activity of molecular signaling systems, called checkpoint processes. Now we may be able to fight back using a new range of molecules, researchers in China report in the European Journal of Medicinal Chemistry. “We have been working on the discovery of anti-cancer agents for more than

Pancreatic cancer cells avert starvation by signaling to nerves, which grow into dense tumors and secrete nutrients. This is the finding of a study with experiments in cancer cells, mice, and human tissue samples published online November 2 in Cell. The study addresses pancreatic ductal adenocarcinoma (PDAC), the deadliest cancer of the pancreas with a

An autoimmune side effect of immune checkpoint inhibitor (ICI) drugs could signal improved control of kidney cancer, according to a new study by researchers in UT Southwestern’s Kidney Cancer Program (KCP). The study, published today in the Journal for ImmunoTherapy of Cancer, may have broad implications for patients being treated with ICIs, a type of

In breakthrough colon cancer research, scientists at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute have discovered a link between two key signaling pathways crucial to the development and growth of colon cancer. The study is published today in the journal PLOS ONE. The scientists identified the link between the retinoic acid or RA

Are the potentially crippling side-effects of new cancer ‘wonder drugs’ worth the risk? Patients with otherwise untreatable tumours benefiting from immunotherapy  The treatment costs around £100,000 per patient per year, and has side-effects One in ten patients given immunotherapy for cancer suffer rheumatoid arthritis Surviving cancer against the odds can give patients a new lease

An experimental vaccine, designed to enlist the body’s own immune system to target cancer cells, has shown promise for treating and preventing cancer in mice. The vaccine was created to target a gene called KRAS that is involved in the development of many types of cancer, including lung, bowel and pancreatic cancer. Researchers from the

Osaka City University detects cancer cells in 2ml blood samples and connects them back to their origin tumor—creating a new diagnostic tool that may aid in quicker and more accurate anti-cancer measures. Using a 2 ml blood sample from 100 gastric cancer patients, researchers succeeded in identifying cancer cells circulating in the bloodstream and trace